Overview

Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and the effect of perioperative chemotherapy in the treatment of advanced gastric cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Capecitabine
Cisplatin
Epirubicin